News - Skolkovo Community
The First Russian Targeted Therapy Drug Developed with the Support of Skolkovo Foundation Has Entered the Clinical Trial Stage in Oncology Anisoprint: Luxembourg an ideal EU base Long-lived roundworms helped identify new anti-aging compounds among the FDA approved drugs Pekka Viljakainen: Startup Village 2019 ...
